Cargando…

Lipid lowering and Alzheimer disease risk: A mendelian randomization study

OBJECTIVE: To examine whether genetic variation affecting the expression or function of lipid‐lowering drug targets is associated with Alzheimer disease (AD) risk, to evaluate the potential impact of long‐term exposure to corresponding therapeutics. METHODS: We conducted Mendelian randomization anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Dylan M., Finan, Chris, Schmidt, Amand F., Burgess, Stephen, Hingorani, Aroon D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944510/ https://www.ncbi.nlm.nih.gov/pubmed/31714636 http://dx.doi.org/10.1002/ana.25642

Ejemplares similares

Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
por: Almramhi, Mona M., et al.
Publicado: (2023)

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
por: Henry, Albert, et al.
Publicado: (2022)

Genetic drug target validation using Mendelian randomisation
por: Schmidt, Amand F., et al.
Publicado: (2020)

No Clinically Relevant Effect of Heart Rate Increase and Heart Rate Recovery During Exercise on Cardiovascular Disease: A Mendelian Randomization Analysis
por: Mensah-Kane, Josephine, et al.
Publicado: (2021)

Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases
por: Howe, Laurence J, et al.
Publicado: (2020)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

Mendelian randomization for studying the effects of perturbing drug targets
por: Gill, Dipender, et al.
Publicado: (2021)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration: A Mendelian Randomization Study
por: Kuan, Valerie, et al.
Publicado: (2021)

Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
por: Sae-jie, Wichanon, et al.
Publicado: (2023)

Mendelian randomization of blood lipids for coronary heart disease
por: Holmes, Michael V., et al.
Publicado: (2015)

Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D
por: Berry, Diane J., et al.
Publicado: (2012)

Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study
por: Williams, Dylan M, et al.
Publicado: (2019)

Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis
por: Schmidt, Amand, et al.
Publicado: (2023)

Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
por: Qin, Hao, et al.
Publicado: (2023)

Mendelian Randomization
por: Burgess, Stephen
Publicado: (2015)

Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis
por: Proitsi, Petroula, et al.
Publicado: (2014)

Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study
por: Tao, Heqing, et al.
Publicado: (2023)

Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Effect of blood lipids and lipid-lowering therapies on osteoarthritis risk: A Mendelian randomization study
por: Wang, Zhaolun, et al.
Publicado: (2022)

A review of instrumental variable estimators for Mendelian randomization
por: Burgess, Stephen, et al.
Publicado: (2015)

Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization study
por: Williams, Dylan M., et al.
Publicado: (2018)

Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions
por: Burgess, Stephen, et al.
Publicado: (2014)

Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
por: Gordillo-Marañón, María, et al.
Publicado: (2021)

Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study
por: Alghamdi, Jahad, et al.
Publicado: (2018)

LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
por: Gratton, Jasmine, et al.
Publicado: (2022)

Educational attainment, structural brain reserve and Alzheimer’s disease: a Mendelian randomization analysis
por: Seyedsalehi, Aida, et al.
Publicado: (2022)

The impact of fatty acids biosynthesis on the risk of cardiovascular diseases in Europeans and East Asians: a Mendelian randomization study
por: Borges, Maria-Carolina, et al.
Publicado: (2022)

Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis
por: Larsson, Susanna C, et al.
Publicado: (2017)

MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data
por: Yavorska, Olena O, et al.
Publicado: (2017)

High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease
por: Zuber, Verena, et al.
Publicado: (2020)

The causes and consequences of Alzheimer’s disease: phenome-wide evidence from Mendelian randomization
por: Korologou-Linden, Roxanna, et al.
Publicado: (2022)

Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis
por: Lou, Chen, et al.
Publicado: (2023)

Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study
por: Zhao, Yangfan, et al.
Publicado: (2022)

Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders
por: Schmidt, A Floriaan, et al.
Publicado: (2023)

Working status and risk of Alzheimer's disease: A Mendelian randomization study
por: Zhao, Jiaxi, et al.
Publicado: (2022)

Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
por: Wu, Tong, et al.
Publicado: (2023)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases
por: Lindbohm, Joni V., et al.
Publicado: (2022)

Selecting instruments for Mendelian randomization in the wake of genome-wide association studies
por: Swerdlow, Daniel I, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4jv2pradhq6ab8i15qlvdq5642